Send to

Choose Destination
ACS Omega. 2017 Dec 31;2(12):9221-9230. doi: 10.1021/acsomega.7b01184. Epub 2017 Dec 27.

Indolizine-Based Scaffolds as Efficient and Versatile Tools: Application to the Synthesis of Biotin-Tagged Antiangiogenic Drugs.

Author information

Univ. Grenoble Alpes, CNRS, DPM, 38000 Grenoble, France.
Univ. Grenoble Alpes, Inserm, CEA, BIG-BCI, 38000, Grenoble, France.
Univ. Grenoble Alpes, CEA, Inserm, BIG-BGE, 38000 Grenoble, France.


We describe the design and optimization of polyfunctional scaffolds based on a fluorescent indolizine core derivatized with various orthogonal groups (amines, esters, oximes, alkynes, etc.). To show one application as tools in biology, the scaffold was used to prepare drug-biotin conjugates that were then immobilized onto avidin-agarose for affinity chromatography. More specifically, the antiangiogenic drug COB223, whose mechanism of action remained unclear, was chosen as a proof-of-concept drug. The drug-selective discrimination of proteins observed after elution of the cell lysates through the affinity columns, functionalized either with the biologically active COB223 or a structurally related inactive analogue (COB236), is a clear indication that the presence of the indolizine core does not limit drug-protein interaction and confirms the usefulness of the indolizine scaffold. Furthermore, the separation of COB223-interacting proteins from human placental extracts unveiled unanticipated protein targets belonging to the family of regulatory RNA-binding proteins, which opens the way to new hypotheses on the mode of action of this antiangiogenic drug.

Conflict of interest statement

The authors declare no competing financial interest.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center